Close Menu
Home » Ginkgo Bio Invests $10M in Transcriptic, Inks Supply Deal With Twist Bioscience

Ginkgo Bio Invests $10M in Transcriptic, Inks Supply Deal With Twist Bioscience

Oct 03, 2017
|
Justin Petrone

NEW YORK (GenomeWeb) – Ginkgo Bioworks today said it will invest more than $10 million over the next five years to incorporate Transcriptic's robotic automation software into its Boston-based foundries.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Hope, But Cost Worries

Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.

Cleared the Committee

The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.

One Gene to Shape the Face

One gene regulates hundreds of others to influence facial development, according to New Scientist.

Nature Studies Review Resources for Single-Cell Analysis, Examine ALS Exomes, More

In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.